Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Arisa OT"'
Autor:
Kasumi Takeuchi, Masayo Ogiso, Arisa Ota, Kentaro Nishimura, Chihiro Nishino, Yasuhiro Omori, Mitsunori Maeda, Ryousuke Mizui, Homare Yamanaka, Tomokazu Ogino, Shigemi Seo
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
Plant diseases caused by soil-borne fungi and oomycetes significantly reduce yield and quality of many crops in the agricultural systems and are difficult to control. We herein examine Pseudomonas rhodesiae HAI-0804, a bacterial biological control ag
Externí odkaz:
https://doaj.org/article/ec9b269d1e6a4ecf9af7aea68ce67d8c
Autor:
Arisa, OT
Incorporation of fluorine into biomolecules provides versatile opportunities for clinical and pre-clinical imaging, with 18F-PET and 19F-MRI and as reporter tags for “zero-background” 19F-NMR. Considerable effort has been made towards achieving d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::0f136cc717dea87b360ca893b9dc472c
https://ora.ox.ac.uk/objects/uuid:f41c102a-886f-4b19-8f4a-3d118c50befe
https://ora.ox.ac.uk/objects/uuid:f41c102a-886f-4b19-8f4a-3d118c50befe
Autor:
Arisa OT; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Beatson EL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Reno A; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Aurigemma R; Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Steeg PS; Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Office of Translational Resources, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Office of Translational Resources, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: figgw@mail.nih.gov.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Dec; Vol. 25 (12), pp. e685-e693.